Were Scott L. Goldberg’s CNO (CNO) share sales under a Rule 10b5-1 plan?

Yes. The Form 4 states Goldberg’s CNO share sales were made under a Rule 10b5-1 trading plan adopted on November 6, 2025. Such pre-arranged plans automate trades and help separate them from short-term market timing decisions.

CNO Financial president exercises options, sells shares

CNO Financial Group President, Consumer Division Scott L. Goldberg reported routine option exercises paired with share sales.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

CNO Financial Group President, Consumer Division Scott L. Goldberg reported routine option exercises paired with share sales. On March 19 and 20, he exercised employee stock options for a total of 22,120 shares of common stock at an exercise price of $21.06 per share. He then sold the 22,120 shares in open-market transactions at weighted average prices of $39.97 and $39.54 per share, executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 6, 2025. Following these transactions, Goldberg directly holds 214,524 shares of CNO Financial Group common stock.

Insider Trade Summary 10b5-1

Exercise and Sale: 22,120 shares ($414K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Goldberg Scott L.

Role President, Consumer Division

Sold 22,120 shs ($879K)

Approx. gross sale proceeds $879K

Approx. exercise cost $466K

Approx. pre-tax spread $414K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	11,060	$0.00	$0.00
Exercise	Common Stock	11,060	$21.06	$233K
Sale	Common Stock	11,060	$39.543	$437K
Exercise	Employee Stock Option (Right to Buy)	11,060	$0.00	$0.00
Exercise	Common Stock	11,060	$21.06	$233K
Sale	Common Stock	11,060	$39.9709	$442K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 contracts (Direct); Common Stock — 214,524 shares (Direct)

Footnotes (4)

F1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025.
F2. Reflects the weighted average sale price. Shares were sold at prices ranging from $39.75 per share to $40.295 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F3. Reflects the weighted average sale price. Shares were sold at prices ranging from $39.28 per share to $39.96 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F4. One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did CNO (CNO) report for Scott L. Goldberg?

Scott L. Goldberg exercised options for 22,120 CNO shares and sold the same number in open-market trades. The transactions combined option exercises and sales, leaving him with 214,524 CNO common shares held directly afterward.

How many CNO (CNO) shares did Scott L. Goldberg sell in this Form 4?

Scott L. Goldberg sold 22,120 CNO common shares in total. The shares came from stock option exercises and were sold in open-market transactions at weighted average prices around $39.97 and $39.54 per share.

At what price did Scott L. Goldberg exercise his CNO (CNO) stock options?

Scott L. Goldberg exercised employee stock options at an exercise price of $21.06 per CNO share. He converted a total of 22,120 options into common stock before selling those shares in subsequent open-market transactions.

How many CNO (CNO) shares does Scott L. Goldberg hold after these transactions?

After completing the option exercises and related sales, Scott L. Goldberg directly holds 214,524 CNO common shares. This post-transaction holding reflects his remaining equity stake reported in the Form 4 filing.

What type of options did Scott L. Goldberg exercise for CNO (CNO)?

He exercised employee stock options labeled as a “Right to Buy” CNO common stock. These options carried an exercise price of $21.06 per share and originally vested in two equal installments in 2019 and 2020, according to the filing footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 03/23/2026 - 04:47 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldberg Scott L.

(Last)

(First)

(Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL

INDIANA

46032

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President, Consumer Division

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/19/2026		M		11,060	A	$21.06	225,584	D
Common Stock	03/19/2026		S		11,060⁽¹⁾	D	$39.9709⁽²⁾	214,524	D
Common Stock	03/20/2026		M		11,060	A	$21.06	225,584	D
Common Stock	03/20/2026		S		11,060⁽¹⁾	D	$39.543⁽³⁾	214,524	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Employee Stock Option (Right to Buy)	$21.06	03/19/2026		M			11,060	⁽⁴⁾	02/23/2027	Common Stock	22,120	$0	11,060	D
Employee Stock Option (Right to Buy)	$21.06	03/20/2026		M			11,060	⁽⁴⁾	02/23/2027	Common Stock	11,060	$0	0	D

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on November 6, 2025.

2. Reflects the weighted average sale price. Shares were sold at prices ranging from $39.75 per share to $40.295 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

3. Reflects the weighted average sale price. Shares were sold at prices ranging from $39.28 per share to $39.96 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.

4. One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR